Anxiety and ADHD: Understanding Comorbidity, Differences, and Treatment

Quick answer: Anxiety and ADHD co-occur in approximately 30 to 50 percent of adults with ADHD and about 25 to 33 percent of children with ADHD, per research from the National Institute of Mental Health (NIMH) and epidemiological surveys. They share overlapping symptoms like restlessness, difficulty concentrating, and sleep problems, but arise from different causes: ADHD is a neurodevelopmental attention and executive-function disorder present from childhood, while anxiety is an emotional state of excessive worry that can emerge at any age. Both often require treatment, and addressing ADHD can sometimes reduce secondary anxiety caused by chronic executive overwhelm. Stimulant medications (first-line ADHD treatment) can worsen or improve anxiety depending on the individual; non-stimulant options and careful sequencing by a clinician are essential. If you are in crisis, call or text 988 (US), 111 option 2 (UK), 112 (EU), or visit findahelpline.com.

How common is anxiety with ADHD?

Anxiety is the most common comorbidity in ADHD. Research shows:

Adults: 30 to 50 percent of adults with ADHD also meet criteria for an anxiety disorder (Kessler et al. 2006, National Comorbidity Survey--Replication; NIMH epidemiology summaries).
Children: 25 to 33 percent of children with ADHD develop an anxiety disorder (CHADD-summarized epidemiology; DSM-5 prevalence data).

This high comorbidity rate reflects both shared biological roots and the psychological impact of untreated ADHD (chronic executive overwhelm, social rejection, repeated failures, and shame can trigger secondary anxiety).

Conversely, primary anxiety can mask or mimic ADHD. Anxiety-driven restlessness, difficulty concentrating during worry, and avoidance can look like inattention or hyperactivity. This is why accurate differential diagnosis is critical.

Why do anxiety and ADHD co-occur?

Shared neurobiology

Both conditions involve dysregulation of the prefrontal cortex (executive control, inhibition) and imbalances in dopamine and norepinephrine, the neurotransmitters that regulate attention, impulse control, and emotional regulation. ADHD is characterized by low dopamine availability in prefrontal regions, leading to reduced focus and impulse control. Anxiety involves hyperactivity in the amygdala (threat detection) and reduced prefrontal inhibition, allowing worry to spiral unchecked. When both are present, the dopamine and norepinephrine dysregulation compounds emotional dysregulation.

Genetic overlap

Twin studies and family histories show genetic overlap between ADHD and anxiety disorders. If a parent has ADHD, their child is more likely to inherit both ADHD and anxiety vulnerability. Heritability estimates suggest shared genetic risk factors, though the specific genes remain under investigation.

Developmental pathway: "ADHD-first" anxiety

Untreated ADHD creates a cascade of experiences that breed anxiety:

Executive overwhelm: A person with undiagnosed ADHD struggles with task initiation, planning, and working memory. Simple projects pile up. Deadlines are missed. Self-doubt grows. The gap between intention and execution widens. Each failure reinforces the belief that they cannot manage their own life.
Rejection sensitivity: ADHD is associated with emotional dysregulation and rejection sensitive dysphoria (RSD), a heightened pain response to perceived or real rejection, criticism, or failure. Repeated social, academic, or professional setbacks fuel anticipatory anxiety ("I will fail again"). This is not just rational caution; it is an emotional amplification. A single piece of critical feedback can trigger shame responses equivalent to traumatic rejection. Anticipatory anxiety develops as a protective mechanism.
Chronic stress: The mismatch between effort and outcome (trying hard but not succeeding) activates the stress-response system chronically. Over months or years, this chronic low-level threat activation shapes the nervous system toward hypervigilance and worry. The HPA axis (hypothalamic-pituitary-adrenal) becomes dysregulated, baseline cortisol may elevate, and the nervous system becomes sensitized to threat.
Internalization of shame: "I must be lazy, stupid, or broken" becomes the belief. Anxiety about one's competence, identity, and future develops. This shame-driven anxiety is relentless: "What if I don't get better? What if this is just who I am?" Rumination deepens the anxiety.

This pathway explains why treating ADHD effectively can sometimes reduce secondary anxiety. By removing the source of chronic overwhelm and failure, the nervous system has a chance to downregulate.

Overlap symptoms: What's the same?

Anxiety and ADHD share several symptoms, creating diagnostic overlap. Clinicians sometimes call this the "anxiety masquerade"—anxiety symptoms can mimic ADHD, and vice versa. This overlap is why a careful developmental history is so important.

Symptom · ADHD · Anxiety · More ADHD? · More Anxiety?

Restlessness / fidgeting · Often present from childhood; chronic physical movement need · Often episodic; triggered by worry; worse with stress/caffeine · Yes · May be episodic

Difficulty concentrating · Hard to focus on non-preferred tasks; easily distracted by competing stimuli · Worry intrudes; mind races with "what-if" scenarios; trouble filtering thoughts · Boredom-driven distraction · Worry-driven distraction

Sleep problems · Difficulty winding down; racing thoughts about non-anxious topics; insomnia or early waking · Difficulty falling asleep due to worry; frequent waking; nightmares · Scattered/hyperarousal · Worry-centered/fear arousal

Irritability · Often present; low frustration tolerance; mood lability · Present during anxiety; heightened reactivity to perceived threat · Chronic baseline · Situational spikes

Forgetfulness / absent-mindedness · Working-memory deficit; lose items, forget appointments · Anxiety can impair encoding due to worry distraction; usually recall intact if not anxious · Chronic baseline · Situational/episodic

Procrastination · Task avoidance due to executive-function paralysis, not fear · Avoidance due to anticipatory anxiety · Initiation paralysis · Fear-driven avoidance

Racing thoughts · Ideas jump; hyperfocus on interesting topic; mind wanders · Rumination; worry spirals; "what-if" loops · Topic-hopping, interest-driven · Worry-loop focused

Why the overlap matters: If you are seeking a diagnosis and describe restlessness and difficulty concentrating, a clinician who relies on symptoms alone might misdiagnose. A person with primary anxiety presenting as restlessness and poor focus might be mislabeled ADHD and prescribed stimulants, which could worsen their anxiety. Conversely, a person with ADHD who develops secondary anxiety might receive anxiety treatment alone, missing the underlying executive-function problem. This is why a thorough assessment includes childhood history, developmental trajectory, and response to treatment trials.

How to tell them apart: Clinical distinctions

Doctors use several markers to differentiate ADHD from anxiety:

1. Onset and developmental history

ADHD: Symptoms present from childhood (before age 12 per DSM-5). Caregivers report "always been like this"—hyperactive toddler, fidgety in school, struggles with homework despite capability.
Anxiety: Can emerge at any age. Clear precipitant or gradual onset of worry. "Was fine until age 20, then started spiraling" or "Worry began after a trauma."

2. Task-focus quality

ADHD: Struggle with boring tasks (executive function needed); excel at interesting ones (hyperfocus). "I can code for 6 hours straight but can't sit through a meeting."
Anxiety: Struggle intensifies with perceived threat or evaluation. "I can focus on interesting things too, but worry about failure hijacks my attention even on things I like."

3. Hyperfocus presence

ADHD: Can hyperfocus on preferred tasks, losing track of time (classic "flow state" but often unable to switch).
Anxiety: Hyperfocus on threat or rumination, not on absorbing, pleasurable tasks.

4. Motor pattern

ADHD: Hyperactivity is chronic and non-contextual. Restless legs, fidgeting, or talking even in relaxed settings.
Anxiety: Restlessness is situational and tied to worry or upcoming perceived threat. Calm down when the threat is resolved.

5. Response to interesting tasks

ADHD: Performance improves; can focus well.
Anxiety: May worsen if the task involves performance pressure or evaluation.

Clinical assessment tools

Doctors use validated rating scales and a structured interview:

ASRS (ADHD Self-Report Scale): 6-item screening, then full 18-item for diagnosis.
GAD-7 (Generalized Anxiety Disorder Scale): 7-item scale, score 5+ suggests anxiety disorder.
Conners Rating Scale: Parent and teacher versions for children.
DSM-5 diagnostic criteria: ADHD requires 6+ inattention OR 6+ hyperactivity/impulsivity symptoms present before age 12, persisting 6+ months, with functional impairment. GAD requires excessive worry 6+ days for 6+ months.

Cite: NIMH ADHD page, CHADD, DSM-5, Mayo Clinic, Cleveland Clinic.

Which comes first: ADHD or anxiety?

Typical sequence: ADHD first, secondary anxiety develops

Most commonly, ADHD is present from childhood (DSM-5 criterion). Anxiety develops later, triggered by the accumulation of failures, social difficulty, and executive overwhelm. Many adults discover they have ADHD after seeking help for anxiety.

Primary anxiety disorder, separate from ADHD

In other cases, a person has a primary anxiety disorder (GAD, social phobia, panic disorder) independent of ADHD. Both can coexist without one causing the other.

Anxiety-first pathway (less common)

In rare cases, childhood anxiety (e.g., school refusal, generalized worry) precedes recognition of ADHD. The anxiety symptoms may have masked or overlapped with ADHD symptoms, delaying diagnosis.

Rejection sensitive dysphoria (RSD): A gray zone

ADHD often involves rejection sensitive dysphoria (RSD), an amplified emotional pain response to perceived or real rejection or criticism. RSD manifests as shame, anger, or intense anxiety about social evaluation. RSD is not the same as an anxiety disorder, but it overlaps clinically and functionally with social anxiety. Both respond to ADHD and anxiety treatment, though the mechanisms differ.

Treatment considerations when you have both

ADHD treatment

First-line medications (stimulants):

Methylphenidate (Ritalin, Concerta) and amphetamines (Adderall, Vyvanse) are the standard first-line treatments.
Stimulants can improve focus and executive function, often reducing the secondary anxiety caused by overwhelm.
But: In some individuals, stimulants worsen anxiety or trigger panic-like symptoms (elevated heart rate, jitteriness, hypervigilance). This is patient-specific and dose-dependent.

Non-stimulant alternatives:

Atomoxetine (Strattera), guanfacine (Intuniv), clonidine (Kapvay), and bupropion (Wellbutrin, off-label) are gentler on the anxiety system.
Often preferred if stimulants worsen anxiety.
Cite: Cochrane reviews on ADHD pharmacotherapy; NIMH; APA Practice Guideline.

Behavioral and structural interventions:

Therapy, coaching, organizational systems, and environmental modification (reduce distractions, break tasks into steps, external reminders).
Often more tolerable for anxiety-prone individuals.

Anxiety treatment when ADHD is present

First-line (psychotherapy):

Cognitive-behavioral therapy (CBT) is the gold standard for anxiety disorders (APA Practice Guideline).
Exposure therapy, acceptance and commitment therapy (ACT), and mindfulness-based approaches are effective.
In ADHD + anxiety, therapy must account for executive-function deficits (shorter sessions, written summaries, homework tracker, accountability).

Medications (SSRIs/SNRIs):

Selective serotonin reuptake inhibitors (sertraline, paroxetine, escitalopram) and serotonin-norepinephrine reuptake inhibitors (venlafaxine) are first-line.
Onset: 2-4 weeks for symptom improvement; 8-12 weeks for full effect.
Avoid benzodiazepines chronically (dependence risk); use only short-term during acute crisis.
Cite: APA Practice Guideline; NIMH; Hofmann and Smits meta-analysis.

Combined treatment approach

Typical sequencing:

Assess and treat the primary condition first (usually ADHD if present from childhood; anxiety if it is clearly the driver of current distress). This is not rigid; the clinician and patient may prioritize based on functional impact and safety.
Monitor the secondary condition carefully. Often, treating the primary condition improves the secondary. For example, treating ADHD with appropriate medication or therapy may reduce anxiety-like symptoms caused by executive overwhelm. Give this 4-6 weeks before assuming it is not working.
If both persist, add targeted treatment for the secondary condition. For example, if stimulants improve ADHD focus but the person still has significant worry, adding an SSRI or therapy for anxiety may be necessary.
Monitor for medication interactions. Stimulants + SSRIs are generally compatible, but dosing and side-effect monitoring are essential. Stimulants can increase serotonin activity (especially amphetamines), so a qualified clinician must supervise. Non-stimulants (atomoxetine, guanfacine) are safer alternatives if stimulants worsen anxiety, as they carry lower risk of serotonin interaction.
Adjust expectations and timeline. ADHD medication takes 1-2 weeks for noticeable effect, titration 2-4 weeks. SSRIs take 2-4 weeks for symptom improvement, 8-12 weeks for full effect. Therapy requires 8-12 sessions before benefit. Patience is critical.

Cite: NIMH ADHD-comorbidity reviews; Cochrane; APA.

Do stimulants make anxiety worse or better?

The answer is both, depending on the individual and the type of anxiety.

Evidence for improvement

Some studies show that stimulant medications, by improving ADHD symptoms, reduce the secondary anxiety caused by executive overwhelm, procrastination, and failure. A person who previously spiraled into "I can't do this" anxiety after starting a task may find that stimulants reduce that barrier, lowering anxiety.

Evidence for worsening

Other studies and clinical observations show that stimulants can increase cardiovascular arousal (elevated heart rate, blood pressure), tremor, and subjective anxiety, particularly at higher doses or in individuals with pre-existing anxiety sensitivity or panic disorder.

The middle ground: Patient-specific response

The net effect depends on:

Baseline anxiety severity: Those with mild anxiety may see improvement; those with panic disorder or generalized anxiety may worsen.
ADHD severity: If ADHD is the primary driver of functional impairment, treating it reduces secondary anxiety.
Dose and formulation: Lower doses or longer-acting formulations (Concerta, Vyvanse) are sometimes better-tolerated than immediate-release or higher doses.
Individual pharmacogenetics: Genetic variation in dopamine and norepinephrine metabolism affects response.

Clinical recommendation: Discuss with your prescriber. Start low, titrate slowly, and monitor anxiety symptoms closely. If stimulants worsen anxiety, non-stimulants or dose reduction are reasonable next steps.

Cite: NIMH ADHD pages; recent ADHD-anxiety comorbidity reviews; Cochrane stimulant trials.

Lifestyle strategies that help both

Exercise

Strong evidence supports aerobic exercise for both ADHD and anxiety (Zaccaro et al. 2018, Hofmann and Smits meta-analysis). Exercise improves dopamine, reduces cortisol, and enhances executive function. Goal: 150 minutes moderate aerobic activity per week.

Sleep

Sleep deprivation worsens both ADHD and anxiety. Executive function, emotional regulation, and impulse control all decline. Anxiety also amplifies sleep difficulty. Prioritize 7-9 hours per night, consistent bedtime, and sleep hygiene (cool, dark room; no screens 1 hour before bed).

Caffeine caution

Caffeine increases heart rate and can worsen both ADHD restlessness and anxiety. Those with ADHD sometimes use caffeine as a self-medication for focus but may inadvertently spike anxiety. Limit to 100-200 mg per day (one cup of coffee) or eliminate if anxiety is present.

Omega-3 fatty acids

Modest evidence suggests omega-3 (EPA/DHA) supplementation may help anxiety (some ADHD studies show small benefits). Food sources (fatty fish) or supplements (1-2 g/day) are low-risk.

Structured routine

Structure and external scaffolding (calendar, task lists, habit stacking, body doubling) reduce ADHD paralysis and the anticipatory anxiety that stems from uncertainty and lack of control.

When to seek help

Seek professional evaluation if you experience:

Functional impairment: Difficulty working, studying, or maintaining relationships due to inattention, hyperactivity, anxiety, or a combination.
Daily symptoms: Inattention, restlessness, worry, or physical anxiety (rapid heart, muscle tension, sleep loss) that occurs most days for 2+ weeks.
Suicidal thoughts or self-harm urges: Immediate crisis resource: 988 (US), 111 option 2 (UK), 112 (EU), findahelpline.com, or 911/999.
Substance use as self-medication: Using alcohol, cannabis, or other drugs to manage ADHD or anxiety symptoms is a sign that professional help is needed.

FAQ

Can ADHD cause anxiety?

Not directly, but untreated ADHD often leads to secondary anxiety through executive overwhelm, social failure, rejection sensitivity, and chronic stress. Treating ADHD can reduce this secondary anxiety. However, if you have a primary anxiety disorder (GAD, social phobia, panic disorder), ADHD treatment alone will not resolve it.

Do stimulants help or hurt anxiety?

Both are possible. Stimulants can improve anxiety by reducing ADHD-driven overwhelm, but they can also worsen anxiety by increasing cardiovascular arousal. The effect is individual. Start low, monitor closely with your prescriber, and consider non-stimulants (atomoxetine, guanfacine) if stimulants worsen anxiety.

What comes first, ADHD or anxiety?

ADHD is usually present from childhood; anxiety often develops later as a secondary response to the stress and failures caused by untreated ADHD. However, primary anxiety disorders can also develop independently. Differential diagnosis requires careful history.

Is rejection sensitive dysphoria (RSD) the same as social anxiety?

RSD and social anxiety overlap but are not identical. RSD is an ADHD-associated amplified emotional pain response to perceived rejection, criticism, or failure. It manifests as shame, anger, or acute distress. Social anxiety is characterized by fear of negative evaluation and avoidance of social situations. Both can coexist; both respond to treatment (ADHD medication/therapy for RSD, anxiety therapy for social anxiety).

Should I treat my ADHD or anxiety first?

There is no one-size-fits-all answer. If ADHD is clearly the primary driver (symptoms from childhood, functional impairment from inattention/hyperactivity), treat that first and reassess anxiety after. If anxiety is the primary cause of current distress or functional impairment, address it first. Many people benefit from concurrent treatment of both. Work with your clinician to develop a sequencing plan.

Can anxiety be misdiagnosed as ADHD?

Yes, occasionally. Anxiety-driven restlessness, worry-induced difficulty concentrating, and avoidance can resemble ADHD. However, the developmental history, task-focus pattern (improves with interesting tasks in ADHD, worsens with performance pressure in anxiety), and presence of hyperfocus (ADHD) or rumination (anxiety) usually clarify. A thorough clinician will use rating scales and childhood history to differentiate.

Do I have both ADHD and anxiety?

Only a clinician can diagnose. If you have struggled with inattention or hyperactivity since childhood AND develop persistent worry or panic, you may have both. Seek evaluation with a psychiatrist, psychologist, or ADHD specialist who can administer rating scales (ASRS, GAD-7, Conners) and take a detailed history.

Does caffeine help or hurt ADHD and anxiety?

Caffeine may briefly improve focus in some people with ADHD (dopamine agonist), but it increases anxiety symptoms (heart rate, jitteriness, sleep disruption). Net effect: often worsens anxiety more than it helps ADHD. Limit or eliminate if anxiety is present.

Internal links

External citations (Tier-1 sources)

NIMH ADHD Overview: https://www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd
DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 5th Edition): American Psychiatric Association, 2013.
Mayo Clinic ADHD & Anxiety: https://www.mayoclinic.org/diseases-conditions/attention-deficit-hyperactivity-disorder-adhd/
Cleveland Clinic: https://my.clevelandclinic.org/health/diseases/
CHADD (Children and Adults with ADHD): https://chadd.org/
ADAA (Anxiety and Depression Association of America): https://adaa.org/
Harvard Health Publishing: https://www.health.harvard.edu/
Kessler et al. (2006) National Comorbidity Survey–Replication: Archives of General Psychiatry. [Epidemiological prevalence of ADHD-anxiety comorbidity]
Cochrane Reviews: Stimulant medications for ADHD; psychotherapy for anxiety disorders.
APA Practice Guideline for Anxiety Disorders: https://www.apa.org/pubs/journals/pra
Hofmann & Smits (2008) meta-analysis on CBT and exercise for anxiety: Clinical Psychology Review.
Zaccaro et al. (2018) on exercise and anxiety: Frontiers in Psychiatry.

Crisis resources

If you are experiencing suicidal thoughts, self-harm urges, or a mental health crisis:

988 Suicide & Crisis Lifeline (US): Call or text 988, available 24/7
111 Option 2 (UK): Mental health crisis support
112 (EU): Emergency services, specify mental health
findahelpline.com: International crisis helpline locator
SAMHSA National Helpline: 1-800-662-4357 (US, substance use & mental health)
Crisis Text Line (US): Text HOME to 741741
Samaritans (UK): 116 123 or email [email protected]

Medical reviewer & methodology note

This post is awaiting review by a qualified medical professional (MD psychiatrist or PhD/PsyD clinician with expertise in ADHD and anxiety comorbidity).

All Ahrefs data (KD, SV, SERP top 10) was retrieved directly from the Ahrefs Keywords Explorer UI in Chrome on 2026-04-23. No Ahrefs API or MCP was used. SERP teardown reflects the top 10 organic results at time of research.